Advanced Search

Save Or Share This Report

For Infrastructure & Operations Professionals

Case Study: CryoPort Turns To Cloud Computing To Develop Tomorrow's New Vaccines

September 9, 2009

Primary author headshot

Authors

Why Read This Report

New-vaccine and pharmaceutical delivery is a very time-sensitive application to say the least, especially when uncertainty can skew test results. CryoPort and KLATU Networks teamed up to build a biological package tracking system that leveraged Amazon Web Services' Elastic Compute Cloud (EC2) to eliminate shipping and storage uncertainty from pharmaceutical transport — and do so at scale. This unique system aggregates all the necessary shipping, customs forms, and temperature logs throughout the packages' journey so the receiving hospital can be confident that the vaccines and pharmaceuticals were handled properly and remain viable for use. By leveraging cloud computing, KLATU can confidently state that the system will be able to scale to more than 40 million shipments per year and thousands of simultaneous users.

Get Access

Already a Client?

Log in to read this document.

Become a Forrester Client

Customers are the new market-makers, reshaping industries and changing how businesses compete and win. Success depends on how well and how fast you respond. Forrester Research gives you insights and frameworks aligned to your role to shorten the time between a great idea and a great outcome, helping your teams win in the age of the customer. Contact us to learn more.

Purchase Report

This report is available for individual purchase ($499 USD).

Purchase

Also in Collection: Best Practices: Infrastructure-As-A-Service (IaaS)

Recommended Research